← Leaderboards
Raman Venkataramanan
University Of Pittsburgh At Pittsburgh
$1,853,498
Attributed
$2,450,664
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $575.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,450,664 · 9
By mechanism
U54$1,104,768 · 2
T32$721,548 · 1
U24$472,785 · 1
P30$102,277 · 1
M01$49,286 · 4
Top collaborators
- Steve N Caritis5 shared
- Timothy W Synold1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Steve N Caritis$23,921,687
- Gary R Matzke$23,366
- Hyagriv N Simhan$12,877,256
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchPregnancyPharmaceutical PreparationsDrug KineticsResponseDosePlasmaPregnant WomenClinical TrialsTrainingTranslational ResearchMultidisciplinaryPharmacodynamicsInvestigationExposure ToClinical PharmacologyHuman SubjectMetabolismBiomarkerDrug ExposureChronicAdultCephalosporinsEnzymes
Grant awards (22)
PITT-CAL ETCTN PK Resource Laboratory$472,785
U24 · FY2025 · CA
Cancer Pharmacokinetics and Pharmacodynamics Facility$102,277
P30 · FY2025 · CA · contact PI
Basic/Translational Investigations on Buprenorphine$200,207
U54 · FY2019 · HD · contact PI
Basic/Translational Investigations on Buprenorphine$242,161
U54 · FY2018 · HD · contact PI
Feasibility and Safety of Vaginal Administration of 17-hydroxyprogesterone caproate$41,953
U54 · FY2018 · HD · contact PI
Basic/Translational Investigations on Buprenorphine$198,353
U54 · FY2017 · HD · contact PI
Basic/Translational Investigations on Buprenorphine$228,264
U54 · FY2016 · HD · contact PI
Training in Basic and Clinical Pharmacology in Pregnancy$194,983
T32 · FY2016 · HD
Feasibility and Safety of Vaginal Administration of 17-hydroxyprogesterone caproate$52,241
U54 · FY2016 · HD · contact PI
Training in Basic and Clinical Pharmacology in Pregnancy$203,153
T32 · FY2015 · HD
Basic/Translational Investigations on Buprenorphine$127,477
U54 · FY2015 · HD · contact PI
Feasibility and Safety of Vaginal Administration of 17-hydroxyprogesterone caproate$14,112
U54 · FY2015 · HD · contact PI
Training in Basic and Clinical Pharmacology in Pregnancy$59,750
T32 · FY2014 · HD
Training in Basic and Clinical Pharmacology in Pregnancy$133,438
T32 · FY2013 · HD
Training in Basic and Clinical Pharmacology in Pregnancy$130,224
T32 · FY2012 · HD
EFFECT OF MILK THISTLE ON THE PHARMACOKINETICS OF MIDAZOLAM$25,315
M01 · FY2005 · RR
EFFECT OF VALERIAN ON PHARMACOKINETICS OF ACETAMINOPHEN$14,323
M01 · FY2005 · RR
MDR1 Gene Polymorphism and Pharmacokinetics of Ritonavir$6,614
M01 · FY2004 · RR
DRUG EXCRETION IN TRANSPLANT PATIENTS$0
M01 · FY2002 · RR
DRUG EXCRETION IN TRANSPLANT PATIENTS$0
M01 · FY2002 · RR
DRUG EXCRETION IN TRANSPLANT PATIENTS$0
M01 · FY2001 · RR
DRUG EXCRETION IN TRANSPLANT PATIENTS$3,034
M01 · FY2000 · RR